Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/424
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Walton, Anthony | - |
dc.contributor.other | Manoharan, Ganesh | - |
dc.contributor.other | Brecker, Stephen | - |
dc.contributor.other | Pasupati, Sanjeevan | - |
dc.contributor.other | Blackman, Daniel | - |
dc.contributor.other | Qiao, Hongyan | - |
dc.contributor.other | Meredith, Ian | - |
dc.date.accessioned | 2015-10-08T05:58:23Z | - |
dc.date.available | 2015-10-08T05:58:23Z | - |
dc.date.issued | 2015-08 | - |
dc.identifier.citation | JACC Cardiovasc Interv. 2015 Aug 24;8(10):1359-67 | en_US |
dc.identifier.issn | 1936-8798 | en_US |
dc.identifier.uri | http://hdl.handle.net/11434/424 | - |
dc.description.abstract | OBJECTIVES: The purpose of this study was to prospectively evaluate the safety and clinical performance of the CoreValve Evolut R transcatheter aortic valve replacement (TAVR) system (Medtronic, Inc., Minneapolis, Minnesota) in a single-arm, multicenter pivotal study in high- or extreme-risk patients with symptomatic aortic valve stenosis. BACKGROUND: Although outcomes following TAVR are improving, challenges still exist. The repositionable 14-F equivalent CoreValve Evolut R TAVR system was developed to mitigate some of these challenges. | en_US |
dc.publisher | Science Direct | en_US |
dc.subject | Victorian Heart Centre, Epworth HealthCare, Melbourne, Australia. | en_US |
dc.subject | Cardiology | en_US |
dc.subject | Cardiac Services | en_US |
dc.subject | Heart Surgery | en_US |
dc.subject | Cardiac Surgery | en_US |
dc.subject | Aortic Valve Stenosis | en_US |
dc.subject | Self-expanding Heart Valve | en_US |
dc.subject | Transcatheter Aortic Valve Replacement | en_US |
dc.subject | Symptomatic Severe Aortic Stenosis | en_US |
dc.title | Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.doi | 10.1016/j.jcin.2015.05.015 | en_US |
dc.identifier.journaltitle | JACC. Cardiovascular Interventions | en_US |
dc.description.pubmeduri | http://www.ncbi.nlm.nih.gov/pubmed/26315740 | en_US |
dc.description.affiliates | Regional Cardiology Department, Royal Victoria Hospital, Belfast, United Kingdom | en_US |
dc.description.affiliates | Cardiology and Interventional Cardiology Services, St. George's Hospital, London, United Kingdom | en_US |
dc.description.affiliates | Department of Cardiology, Waikato Hospital, Hamilton, New Zealand | en_US |
dc.description.affiliates | Department of Cardiology, Leeds General Infirmary, Leeds, United Kingdom | en_US |
dc.description.affiliates | Statistical Services, Medtronic, Inc., Minneapolis, Minnesota | en_US |
dc.description.affiliates | Department of Medicine, Monash University, Melbourne, Australia | en_US |
dc.description.affiliates | Monash Health, Melbourne, Australia | en_US |
dc.description.affiliates | MonashHEART, Melbourne, Australia | en_US |
dc.description.affiliates | Monash Cardiovascular Research Centre, Melbourne, Australia | en_US |
dc.type.studyortrial | Prospective Cohort Study | en_US |
dc.type.contenttype | Text | en_US |
Appears in Collections: | Cardiac Sciences |
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.